Crossmark

High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada

Crossref DOI link: https://doi.org/10.1186/s12889-018-5180-8

Published Online: 2018-02-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wilton, James

Noor, Syed W.

Schnubb, Alexandre

Lawless, James

Hart, Trevor A.

Grennan, Troy

Fowler, Shawn

Maxwell, John

Tan, Darrell H. S. http://orcid.org/0000-0002-3069-2875
Funding

Funding for this research was provided by:

Ontario HIV Treatment Network (RFA G842A)

Canadian Institutes of Health Research (CBR 134793)
More Information

Article History

Received: 15 September 2017

Accepted: 19 February 2018

First Online: 27 February 2018

Ethics approval and consent to participate

: The study was approved by the Research Ethics Boards of St. Michael’s Hospital, Ryerson University, and the University of Toronto. Informed consent was obtained prior to the collection of study data.

: Not applicable.

: DHST has received honoraria from Merck, Abbvie, Gilead and Viiv Healthcare for developing educational lectures; investigator-driven grants from Gilead and Viiv Healthcare; and clinical trial contracts from Gilead and GSK. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.